Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 7NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 61Leukemia 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Myelomonocytic, Acute 33Leukemia, Monocytic, Acute 29Congenital Abnormalities 28Leukemia, Erythroblastic, Acute 26Leukemia, Megakaryoblastic, Acute 25Lymphoma 24Myelodysplastic Syndromes 18Burkitt Lymphoma 16Leukemia, Myelomonocytic, Chronic 13Anemia, Refractory, with Excess of Blasts 13Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Myeloproliferative Disorders 11Leukemia, Eosinophilic, Acute 11Leukemia, Basophilic, Acute 11Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Follicular 8Blast Crisis 8Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Lymphoma, Mantle-Cell 6Leukemia, Promyelocytic, Acute 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5

Interventions

fludarabine phosphate 3Cyclophosphamide 3Antilymphocyte Serum 3tipifarnib 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Isotretinoin 2Cytarabine 2Busulfan 2Biopsy 2trametinib 1thymoglobulin 1omipalisib 1Vorinostat 1Transplantation 1Tacrolimus 1Sorafenib 1Radiation 1Polymerase Chain Reaction 1Mycophenolic Acid 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Melphalan 1MK 2206 1Flow Cytometry 1Filgrastim 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Leukemia, Myelomonocytic, Juvenile × Cytarabine × Clear all
NCT00047268 2013-09-17

Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00025038 2013-04-11

Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡